| | | Pancreatic adenocarcinoma + incidental liver metastases | Nonmetastasized pancreatic adenocarcinoma | P value |
| | Number of patients | 22 | 22 | | | Mean age (years/range) | 57.5 (31–78) | 57.5 (42–74) | | | Gender (male) | 14 (64%) | 14 (64%) | | | Tumor-associated symptoms | | | | | Weight loss | 9 (41%) | 8 (36%) | | | Jaundice | 11 (50%) | 13 (59%) | | | Epigastric pain | 13 (59%) | 12 (55%) | | | Mean body-mass-index (range) | 23.4 (17.7–31.2) | 23.6 (18.7–30.5) | | | Mean CA 19-9 (ku/L) | 8427,6 | 1019,9 | 0.322 | | Mean CEA (ug/L) | 14.3 | 5.8 | 0.116 | | Mean bilirubin (mg/dL) | 5.0 | 4.7 | 0.911 | | Mean quick (TPZ) | 103.7 | 97.2 | 0.125 | | Mean albumin (IU) | 4.2 | 3.7 | 0.113 | | Preoperative endoscoping stenting | 15 (68%) | 15 (68%) | |
|
|